表紙
市場調査レポート

Hadasit Medical Research Services & Development Ltdの製品パイプライン分析

Hadasit Medical Research Services & Development Ltd - Product Pipeline Review - 2015

発行 Global Markets Direct 商品コード 251671
出版日 ページ情報 英文 24 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.50円で換算しております。
Back to Top
Hadasit Medical Research Services & Development Ltdの製品パイプライン分析 Hadasit Medical Research Services & Development Ltd - Product Pipeline Review - 2015
出版日: 2015年07月15日 ページ情報: 英文 24 Pages
概要

当レポートでは、Hadasit Medical Research Services & Development Ltdの製品開発パイプラインの現況と各開発段階の比較分析、薬剤のプロファイル、パイプラインの分析と最新の動向、休止中のプロジェクトなどの情報を提供しています。

Hadasit Medical Research Services & Development Ltdの基本情報

Hadasit Medical Research Services & Development Ltdの概要

  • 主要情報
  • 企業情報

Hadasit Medical Research Services & Development Ltd:R&Dの概要

  • 主な治療範囲

Hadasit Medical Research Services & Development Ltd:パイプラインのレビュー

  • 開発段階別のパイプライン製品
  • 単剤製品
  • パートナー製品
    • パートナー製品/併用療法モダリティ

Hadasit Medical Research Services & Development Ltd:パイプライン製品の概況

  • 初期段階にあるパイプライン製品
    • 前臨床段階にある製品/併用療法モダリティ
    • 創薬中の製品/併用療法モダリティ

Hadasit Medical Research Services & Development Ltd:薬剤プロファイル

  • HYPER-IL-6
  • 2型糖尿病およびインスリン抵抗性のためのプロテインキナーゼCを阻害する合成ペプチド
  • HIVワクチン
  • 腫瘍治療のための合成ペプチド

Hadasit Medical Research Services & Development Ltd:パイプライン分析

  • 標的別
  • 分子タイプ別
  • 作用機序別

Hadasit Medical Research Services & Development Ltd:休止中のプロジェクト

Hadasit Medical Research Services & Development Ltd:本社と子会社の所在地

付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GMDHC07332CDB

Summary

Global Markets Direct's, 'Hadasit Medical Research Services & Development Ltd - Product Pipeline Review - 2015', provides an overview of the Hadasit Medical Research Services & Development Ltd's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Hadasit Medical Research Services & Development Ltd's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Hadasit Medical Research Services & Development Ltd including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Hadasit Medical Research Services & Development Ltd's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Hadasit Medical Research Services & Development Ltd's pipeline products

Reasons to buy

  • Evaluate Hadasit Medical Research Services & Development Ltd's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Hadasit Medical Research Services & Development Ltd in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Hadasit Medical Research Services & Development Ltd's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Hadasit Medical Research Services & Development Ltd and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Hadasit Medical Research Services & Development Ltd
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Hadasit Medical Research Services & Development Ltd and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Hadasit Medical Research Services & Development Ltd Snapshot
    • Hadasit Medical Research Services & Development Ltd Overview
    • Key Information
    • Key Facts
  • Hadasit Medical Research Services & Development Ltd - Research and Development Overview
    • Key Therapeutic Areas
  • Hadasit Medical Research Services & Development Ltd - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Partnered Products
      • Partnered Products/Combination Treatment Modalities
  • Hadasit Medical Research Services & Development Ltd - Pipeline Products Glance
    • Hadasit Medical Research Services & Development Ltd - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • Hadasit Medical Research Services & Development Ltd - Drug Profiles
    • HYPER-IL-6
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Synthetic Peptide to Inhibit Protein Kinase C for Type 2 Diabetes and Insulin Resistance
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • HIV vaccine
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Synthetic Peptides for Oncology
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Hadasit Medical Research Services & Development Ltd - Pipeline Analysis
  • Hadasit Medical Research Services & Development Ltd - Pipeline Products by Target
  • Hadasit Medical Research Services & Development Ltd - Pipeline Products by Molecule Type
  • Hadasit Medical Research Services & Development Ltd - Pipeline Products by Mechanism of Action
  • Hadasit Medical Research Services & Development Ltd - Dormant Projects
  • Hadasit Medical Research Services & Development Ltd - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Hadasit Medical Research Services & Development Ltd, Key Information
  • Hadasit Medical Research Services & Development Ltd, Key Facts
  • Hadasit Medical Research Services & Development Ltd - Pipeline by Indication, 2015
  • Hadasit Medical Research Services & Development Ltd - Pipeline by Stage of Development, 2015
  • Hadasit Medical Research Services & Development Ltd - Monotherapy Products in Pipeline, 2015
  • Hadasit Medical Research Services & Development Ltd - Partnered Products in Pipeline, 2015
  • Hadasit Medical Research Services & Development Ltd - Partnered Products/ Combination Treatment Modalities, 2015
  • Hadasit Medical Research Services & Development Ltd - Preclinical, 2015
  • Hadasit Medical Research Services & Development Ltd - Discovery, 2015
  • Hadasit Medical Research Services & Development Ltd - Pipeline by Target, 2015
  • Hadasit Medical Research Services & Development Ltd - Pipeline by Molecule Type, 2015
  • Hadasit Medical Research Services & Development Ltd - Pipeline Products by Mechanism of Action, 2015
  • Hadasit Medical Research Services & Development Ltd - Dormant Developmental Projects,2015

List of Figures

  • Hadasit Medical Research Services & Development Ltd - Pipeline by Top 10 Indication, 2015
  • Hadasit Medical Research Services & Development Ltd - Pipeline by Stage of Development, 2015
  • Hadasit Medical Research Services & Development Ltd - Monotherapy Products in Pipeline, 2015
  • Hadasit Medical Research Services & Development Ltd - Pipeline by Top 10 Target, 2015
  • Hadasit Medical Research Services & Development Ltd - Pipeline by Top 10 Molecule Type, 2015
  • Hadasit Medical Research Services & Development Ltd - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top